ISRCTN92067975进行中（未招募）4 期
Reintroduction of anti-tuberculosis therapy following drug-induced liver injury: a randomised controlled trial (TB-DILI)
ottingham Clinical Trials Unit0 个研究点目标入组 350 人开始时间: 2022年8月25日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged =18 years
- •2. Experienced DILI with standard 4-drug ATT for active pulmonary or extra-pulmonary TB
- •3. Medically suitable
- •4. for re-introduction of standard 4-drug ATT
排除标准
- •1. Requirement for alternative ATT
- •2. Unable to provide written informed consent
研究者
相似试验
已完成
不适用
Study on reintroduction regimen of antituberculous therapy after developing of drug-induced hepatotoxicity (DIH)tuberculosisJPRN-UMIN000008069ational Center for Global Health and Medicine50
已完成
不适用
Mycobacteria infection in incomplete transverse myelitisIncomplete transverse myelitis (ITM)Nervous System DiseasesEncephalitis, myelitis and encephalomyelitisISRCTN57081310Sun Yat-sen University (China)67
招募中
2 期
The tuberculosis treatments by anti-tuberculosis dry powder prepared as nano-particulate system for inhaling into the respiratory systempatient with pulmonary tuberculosispulmonary tuberculosis treatment,dry powder inhalerTCTR20190404002Government Pharmaceutical Organization (GPO)208
已完成
不适用
Initial Loss to Follow Up Among Tuberculosis Patients: The Role of Ward-Based Outreach Teams and Short Message Service (SMS) TechnologyTuberculosisPACTR202101914895981Consortium for Advanced Research Training in Africa312
尚未招募
4 期
Test and Treat to End Tuberculosis (TB): A screening and treatment study for children and adults with Latent Tuberculosis Infection (LTBI)tuberculosisatent Tuberculosis InfectionLatent Tuberculosis InfectionRespiratory - Other respiratory disorders / diseasesInfection - Other infectious diseasesPublic Health - EpidemiologyPublic Health - Health service researchACTRN12622000115730Woolcock Institute of Medical Research208,000